Healio1h
Impacts of CAR T-cell therapy in lupus often ‘not captured on SLEDAI’
Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...
Lupus Foundation of America22h
FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...
Study: Misdiagnosis of lupus symptoms linked to mental health, trust issues
Patients whose autoimmune disorders such as lupus were initially dismissed by doctors as psychosomatic show long-lasting ...
Contract Pharma20h
FDA Accepts Roche’s sBLA for Lupus Nephritis Treatment
Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...